Humira and Botox maker AbbVie is suing the Trump administration to get a clearer definition of who counts as an eligible ...
Pharmaceutical companies are spending hundreds of millions lobbying elected officials to try and persuade them to gut the ...
Drug companies want to end it. This is not a partisan issue. It is a math issue. And for the patients and communities we serve, it is a survival issue.
(Corrects paragraph 8 to clarify the potential impact of AbbVie's lawsuit.) April 8 (Reuters) - AbbVie has filed a lawsuit ...
A federal court has struck down a 12-year-old Health Resources and Services Administration policy that restricted how certain 340B hospitals could make initial drug purchases, finding that the agency ...
A federal judge has, at least temporarily, nixed a longstanding restriction on whether some 340B hospitals could use group ...
Tuesday’s bill gives powers to the Attorney General’s Office to further enforce state law that prohibits manufacturers from ...
"The savings from this program support pharmacy services, emergency care, behavioral health, and care for patients who are ...
US pharma major AbbVie (NYSE: ABBV) has filed a lawsuit seeking to narrow the definition of a “340B patient,” opening a new ...
Catholic healthcare was not started nor inspired from profit and loss statements or a desire to drive more shareholder value. Instead, through acts of mercy, women religious crossed oceans on ...
The secretary of Indiana’s Family and Social Services Administration wants to change how hospitals purchase discounted drugs ...
PharmaForce, a leader in modern 340B program management, today announced the appointment of Lynn Eschenbacher, PharmD, MBA, FASHP, as Chief Pharmacy and Strategy Officer, reinforcing its commitment to ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results